secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2025-07-30T23:59:59+00:00
Accession:  0000816956-25-000026
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED Q2 adj EPS $1.15 beats; raises FY2025 revenue and adj EPS guidance
-------------------------------------------------------------------------

- Q2 sales $342.3M (+3.1% YoY); GAAP EPS $0.69 (down from $0.96), adj EPS $1.15 (up from $0.98).
- Single-use products +6.6% to $297.8M; capital products -15.5% to $44.5M.
- FY revenue guidance raised to $1.356B-1.378B; adj EPS raised to $4.40-4.55 (prior $4.31-4.46).
- Company estimates ~$0.09 EPS headwind from tariffs in H2 2025.
- Operational optimization consulting fees $7.6M in Q2; exec transition costs $12.2M YTD.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000081695625000026/0000816956-25-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000081695625000026/cnmd-20250730.htm
  HTML page:      https://secwatch.observer/filing/0000816956-25-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer